Retardation of Growth of Walker Rat Carcinoma 256 by Administration of Diethyl Riboflavin.
- 1 October 1951
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 78 (1) , 197-199
- https://doi.org/10.3181/00379727-78-19019
Abstract
Young, 31-45 g. male Sprague-Dawley rats in which Walker carcinoma 256 transplants were made showed, after 21 days, an 8 g. greater retention of their carcass tissue when receiving 30 [mu] g. diethylriboflavin than pair fed controls receiving an equimolar amt. of riboflavin. The avg. tumor size, expressed as % total body wt., of the diethylriboflavin group was 20% while the avg. tumor size of the riboflavin group was 30%, indicating a 33% inhibition of the growth of the tumors due to the admn. of diethylriboflavin.Keywords
This publication has 0 references indexed in Scilit: